5.5 – Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency
circumstances of the COVID-19 pandemic and will continue to be studied after provision
of the Vaccine to Purchaser under this Agreement. Purchas er further acknowledges that
the long-term effects and efficacy of the Vaccine are not currently known and that there
may be adverse effects of the Vaccine that are not currently known. Further, to the extent
applicable, Purchaser acknow ledges that the Product shall not be serialized.
Page 21 of 46
8.8 – Indemnification by Purchaser. Purchaser hereby agrees to indemnify, defend and hold
harmless Pfizer, BioNTech, each of their Affiliates, contractors, sub-contractors, li censors,
li censees, sub- li censees, distributors, contract manufacturers, services providers, clinical
trial researchers, third parties to whom Pfizer or BioNTech or any of their respective
Affiliates may directly or indire ct ly owe an indemnity based on the research, development,
manufacture, distribution, commercialization or use of the Vaccine, and each of the
officers, directors, emp loyees and other agents and representatives, and the respective
predecessors, successors and assigns of any of the foregoing (“Indernnitees”), from a nd
again st any and a ll suits, cla ims, act ions, demands, losses, damages, li abilities, settlements,
Page 23 of 46
cont’d – penalties, fines, costs and expenses (including, without limitation, reasonable attorneys’
and other counsels’ fees and other expenses of an investigation or litigation), whether
sounding in contract, tort (delict), intellectual property, or any other theory, and whether
legal, statutory, equitable or otherwise by any natural or legal person (collectively,
“Losses”) caused by, arising out of, relating to, or resulting from the Vaccine, including
but not limited to any stage of design, development, investigation, formulation, testing,
clinical testing, manufacture, labeling, packaging, transport, storage, distribution,
marketing, promotion, sale, purchase, · licensing, donation, dispensing, prescribing,
administration, provision, or use of the Vaccine, any information, instructions, advice or
guidance provided by Pfizer, or BioNTech or any of their respective Affiliates and relating
to the use of the Vaccine, or any processing or transfer of anyone’s personal information
processed and transferred by Purchaser to the Indemnitees (“Covered Activities”).
8.6 – Costs. Costs and expenses, including, without limitation, fees and disbursements of
counsel, incurred by the Indemnitee(s) in connection with any Indemnified Claim shall be
reimbursed on a qua,terly basis by Purchaser, without prejudice to Purchaser’s right to
refund in the event that Purchaser is ultimately held in a final, non-appealable judgment or
award to be not obligated to indemnify the Indemnitee(s)
9.4 – Waiver of Sovereign Immunity . Purchaser, on be half of itself and the Republic of South
Africa, expressly and irrevocab ly waives any right of immuni ty which either it or its assets
may have or acquire in the future (whether characterized as sovereign immunity or any
other type of immunity), including any assets controlled by any agency, instrumentality,
central bank, or monetary authority of the Republic of South Africa
Purchaser, on behalf of itself and the Republic of South Africa,
further covenants and agrees not to assert any such immunity in any proceeding in
connection with this Agreement. Purchaser, on behalf of itse lf and the Republic of Sou th
Africa expressly and irrevocably submits to the jurisdiction of the courts of New York , or
any other cou1t of competent jurisdiction, for the purposes of enforcing any arbitral
decision, order or awa rd, or any settlement in connection with any arbitration pursuant to
Section 12.2 and represents and warrants that the person signing this Agreement on its
behalf has actual authority to submit to such jurisdiction. Purchaser also expressly and
irrevocably waives the application of any Law in any jurisdiction that may otherwise limit
or cap its ob ligation to pay damages arising from or in connection with any In demnified
Claims. Purchaser repre se nts and warrants that the person signing this Agreement on its
behalf has actua l authority to waive such immunity and bind Purchaser and the Republic
of Sout h Africa to the limitations of li ab ility and liability waivers set forth herein
9.6 – Conditions Precedent to Supply.
b) (iii)
Purchaser must demonstrate, in a mann er satisfactory to Pfizer, that Pfizer
and its affiliates will have adequate protection, as determined in Pfizer ‘s
sole discretion, from li ability for claims a ri sing out of or in connection with
the Vaccine or its use, including but not limited to, that the Republic of
South Africa w ill continue funding the Dedicated Fund to meet any and a ll
indemnification obligations, and wi ll provide as a condition precedent to the
s igning of this Agreement and supply of doses, documentation showing
autho ri zati on for the indemnification obligations
If this is the same contract that all governments signed, which it most likely is then, it is prima facie evidence that Johnson, Handcock, Whitty and Vallance and plenty others, were lying through their teeth when they told us it was “safe and effective”
They KNEW that was not verifiable so they were lying. No surprise from obvious lying liars like Johnson and Handcock. But the medical “professionals” should surely have known better
Convenient timing to release this when everybody is fixated on Gaza and the ongoing genocide there
Join us for the first The Alternative View Presents with Gary Fraughen
Gary will be sharing his research and speaking about many subjects including:
Blue shift radiation
Super fluid consciousness with servants Savants and greed
Numbers in the cracks and crevices of the universe
The universal balance sheet of doing harm to others
This is your opportunity to get up close and personal with Gary. This will be a more intimate event with plenty of opportunity for questions and discussion.
A big thank you to those of you who attended the AV13 Conference in Milton Keynes. It was fantastic to finally get back together and welcome old friends and newcomers to a very enjoyable and memorable event. We are already already working on the next AV events.
If you didn't make it to AV13 we now have the presentation recordings available.
To watch please click on any video and purchase a ticket. Once you have made your purchase you will be sent an automatic email confirmation with your password details. You have unlimited viewings for the duration of your ticket.
Important: Please check your spam folder after your purchase as sometimes the confirmations go to spam. If you don't receive your password within 10 mins please contact us. We also have a help page. www.alternativeview.co.uk/help-page
5.5 – Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency
circumstances of the COVID-19 pandemic and will continue to be studied after provision
of the Vaccine to Purchaser under this Agreement. Purchas er further acknowledges that
the long-term effects and efficacy of the Vaccine are not currently known and that there
may be adverse effects of the Vaccine that are not currently known. Further, to the extent
applicable, Purchaser acknow ledges that the Product shall not be serialized.
Page 21 of 46
https://healthjusticeinitiative.org.za/wp-content/uploads/2023/09/OCRPfizer-1_Redacted.pdf
8.8 – Indemnification by Purchaser. Purchaser hereby agrees to indemnify, defend and hold
harmless Pfizer, BioNTech, each of their Affiliates, contractors, sub-contractors, li censors,
li censees, sub- li censees, distributors, contract manufacturers, services providers, clinical
trial researchers, third parties to whom Pfizer or BioNTech or any of their respective
Affiliates may directly or indire ct ly owe an indemnity based on the research, development,
manufacture, distribution, commercialization or use of the Vaccine, and each of the
officers, directors, emp loyees and other agents and representatives, and the respective
predecessors, successors and assigns of any of the foregoing (“Indernnitees”), from a nd
again st any and a ll suits, cla ims, act ions, demands, losses, damages, li abilities, settlements,
Page 23 of 46
cont’d – penalties, fines, costs and expenses (including, without limitation, reasonable attorneys’
and other counsels’ fees and other expenses of an investigation or litigation), whether
sounding in contract, tort (delict), intellectual property, or any other theory, and whether
legal, statutory, equitable or otherwise by any natural or legal person (collectively,
“Losses”) caused by, arising out of, relating to, or resulting from the Vaccine, including
but not limited to any stage of design, development, investigation, formulation, testing,
clinical testing, manufacture, labeling, packaging, transport, storage, distribution,
marketing, promotion, sale, purchase, · licensing, donation, dispensing, prescribing,
administration, provision, or use of the Vaccine, any information, instructions, advice or
guidance provided by Pfizer, or BioNTech or any of their respective Affiliates and relating
to the use of the Vaccine, or any processing or transfer of anyone’s personal information
processed and transferred by Purchaser to the Indemnitees (“Covered Activities”).
8.6 – Costs. Costs and expenses, including, without limitation, fees and disbursements of
counsel, incurred by the Indemnitee(s) in connection with any Indemnified Claim shall be
reimbursed on a qua,terly basis by Purchaser, without prejudice to Purchaser’s right to
refund in the event that Purchaser is ultimately held in a final, non-appealable judgment or
award to be not obligated to indemnify the Indemnitee(s)
9.4 – Waiver of Sovereign Immunity . Purchaser, on be half of itself and the Republic of South
Africa, expressly and irrevocab ly waives any right of immuni ty which either it or its assets
may have or acquire in the future (whether characterized as sovereign immunity or any
other type of immunity), including any assets controlled by any agency, instrumentality,
central bank, or monetary authority of the Republic of South Africa
Purchaser, on behalf of itself and the Republic of South Africa,
further covenants and agrees not to assert any such immunity in any proceeding in
connection with this Agreement. Purchaser, on behalf of itse lf and the Republic of Sou th
Africa expressly and irrevocably submits to the jurisdiction of the courts of New York , or
any other cou1t of competent jurisdiction, for the purposes of enforcing any arbitral
decision, order or awa rd, or any settlement in connection with any arbitration pursuant to
Section 12.2 and represents and warrants that the person signing this Agreement on its
behalf has actual authority to submit to such jurisdiction. Purchaser also expressly and
irrevocably waives the application of any Law in any jurisdiction that may otherwise limit
or cap its ob ligation to pay damages arising from or in connection with any In demnified
Claims. Purchaser repre se nts and warrants that the person signing this Agreement on its
behalf has actua l authority to waive such immunity and bind Purchaser and the Republic
of Sout h Africa to the limitations of li ab ility and liability waivers set forth herein
9.6 – Conditions Precedent to Supply.
b) (iii)
Purchaser must demonstrate, in a mann er satisfactory to Pfizer, that Pfizer
and its affiliates will have adequate protection, as determined in Pfizer ‘s
sole discretion, from li ability for claims a ri sing out of or in connection with
the Vaccine or its use, including but not limited to, that the Republic of
South Africa w ill continue funding the Dedicated Fund to meet any and a ll
indemnification obligations, and wi ll provide as a condition precedent to the
s igning of this Agreement and supply of doses, documentation showing
autho ri zati on for the indemnification obligations
If this is the same contract that all governments signed, which it most likely is then, it is prima facie evidence that Johnson, Handcock, Whitty and Vallance and plenty others, were lying through their teeth when they told us it was “safe and effective”
They KNEW that was not verifiable so they were lying. No surprise from obvious lying liars like Johnson and Handcock. But the medical “professionals” should surely have known better
Convenient timing to release this when everybody is fixated on Gaza and the ongoing genocide there